Skip to main content
186kviews
Editorial13 March 2024
Editorial: Micronutrients and metabolic diseases

micronutrients in metabolic diseases remain unclear, emphasizing the importance of continued investigation on the relationship in this field.Research topic "micronutrients and metabolic diseases" comprises 22 articles covering the epidemiological and mechanistic studies investigating micronutrient metabolism and their influence on human health. Several articles in this issue systematically evaluated the associations of micronutrients and cardiometabolic risk factors with risk of metabolic diseases. Zhang et al.summarized the relationship among metal ion concentrations and multiple metabolic diseases based on recent studies using ionomic or multi-elemental profiling of different biological samples, (7). Vahid et al. evaluated the association between micronutrient intake and obese/overweight in a case-control population consisting of 1,605 participants (8). Another prospective cross-sectional study reported that dietary magnesium and potassium intake were associated with lower body fat in 155 Chinese participants with impaired glucose tolerance (9). Wan et al. investigated the associations between blood toxic and essential metals with blood lipids, and observed blood lead and blood magnesium concentrations were associated with the dyslipidemia in 998 participants living in Southern China (10). In a study involving 3,858 Chinese with papillary thyroid microcarcinoma, higher iodine intake was reported to be a risk factor for nodal metastasis (11).Additionally, a case-control study with 1012 participants found that dietary intakes of calcium, magnesium, iron, zinc, and copper were inversely associated with the odds of glioma (12). These findings suggest that mineral status could serve as valuable indicators for the early detection and prognosis of some metabolic diseases, emphasizing the significance of maintaining adequate and balanced intake of certain micronutrient for overall human health.For the role of a specific mineral, four articles discussed the role of iron in metabolic diseases.

deficiency anemia risk during pregnancy in a prospective study of 353 Chinese women (13). Qiu et al. explored the causal association between systemic iron status and 24 specific mental disorders, revealing a detrimental effect of higher body iron stores on depression and psychogenic disorder (14). A mechanistic study by Bengson et al. dissected iron homeostasis in neural cells, and revealed that ferritinophagy could be implicated in the pathogenesis of neurodegenerative diseases (15). In the review article by Bao et al., the mechanistic connection between abnormal iron metabolism and osteoporosis induced by diabetes mellitus was discussed (16).Vitamin D deficiency or insufficiency has been identified as risk factors for cardiometabolic diseases (17). In this research topic, three original studies investigated the associations of vitamin D with cardiometabolic risk factors and related diseases. In a prospective cohort study involving 1,926 individuals, blood vitamin D concentration displayed a non-linear association with risk of type 2 diabetes during a mean follow-up of three years (18). A cross-sectional study conducted by Shan et al. assessed the association of vitamin D with metabolic syndrome and related risk factors in 1,505 female Chinese (18). Chen et al. performed a mechanistic study to evaluate whether vitamin D deficiency during pregnancy could alter the metabolism of glucose and lipids in offspring. Vitamin D deficiency during pregnancy generated adverse effects on the metabolism of glucose and lipids in offspring. Notably, these adverse effects cannot be rescued via vitamin D supplementation after weaning, suggesting that maternal vitamin D deficiency may elevate the risk of metabolic disease for offspring in adulthood (19).Four articles in this research topic explored the cardiovascular benefits of phytochemicals.Guo et al. comprehensively reviewed the antioxidant, anti-inflammatory, anti-hypertensive and lipid-lowering effects of tea polyphenols, as well as the underlying molecular mechanisms (20). In a meta-analysis of 39 randomized controlled trials by Micek et al., the impact of polyphenols from 100% fruit juices on cardiometabolic risk factors was assessed. They found that anthocyanins were shown to decrease total cholesterol and low-density lipoprotein cholesterol in a doseresponse manner (21). Another cross-sectional analysis of 12,424 adults from the United States National Health and Nutrition Examination Survey reported that serum carotenoid concentrations were inversely associated with the odds of cardiovascular diseases, especially heart attack and stroke (22). Moreover, Zhu et al. conducted a functional study to improve the delivery efficiency of phytochemicals nuciferine and epigallocatechin-3-gallate via loading them into microgel. Oral administration of microgel containing these phytochemicals reduced serum lipids of rats receiving high-fat diet, likely by modulating key genes involved in lipid metabolism and improving the diversity of gut microbiota (23).Despite of abovementioned works, articles in this research topic also explored the associations of vitamin B1 (24), niacin (25), zinc (26), and calcium (27) with cardiometabolic diseases. These articles provided novel epidemiological evidence on the impact of micronutrients on health outcomes and offer mechanistic insights into micronutrient metabolism. The collective findings hold promise for guiding the development of healthier dietary patterns and more effective strategies for the prevention of cardiometabolic diseases.

3,795 views

3 citations

ORIGINAL RESEARCH
31 August 2023
Association of vitamin B1 with cardiovascular diseases, all-cause and cardiovascular mortality in US adults
He Wen, 6 more and Wei Zhang

35,188 views

21 citations

ORIGINAL RESEARCH
11 August 2023
Sucrose-induced hyperglycemia dysregulates intestinal zinc metabolism and integrity: risk factors for chronic diseases
Samuel Blake Mitchell, 6 more and Tolunay Beker Aydemir

6,669 views

20 citations

BRIEF RESEARCH REPORT
15 August 2023
Elevated first-trimester hepcidin level is associated with reduced risk of iron deficiency anemia in late pregnancy: a prospective cohort study
Peng Sun, 8 more and Yanna Zhu

4,388 views

7 citations

ORIGINAL RESEARCH
31 August 2023
Association between iodine nutrition and cervical lymph node metastasis of papillary thyroid microcarcinoma
Hengqiang Zhao, 3 more and Tao Huang

4,143 views

5 citations

ORIGINAL RESEARCH
31 August 2023
Free and bioavailable 25-hydroxyvitamin D thresholds for bone metabolism and their associations with metabolic syndrome in Chinese women of childbearing age
Xiaoyun Shan, 5 more and Lichen Yang

2,435 views

5 citations

ORIGINAL RESEARCH
12 July 2023
The protective effect of serum carotenoids on cardiovascular disease: a cross-sectional study from the general US adult population
Min Wang, 3 more and Dongmei Di
The protective effect of serum carotenoids on cardiovascular disease: a cross-sectional study from the general US adult population
Background: Cardiovascular disease (CVD) has become a key global health issue. Serum carotenoids are associated with CVD, while their effects on different diseases remain unclear. Herein, the relationship between the concentration of serum carotenoid and the CVD risk was investigated using nationwide adult samples obtained from the USA. Materials and methods: Data of National Health and Nutrition Examination Survey (NHANES) in 2001-2006 were employed. The association of serum carotenoids (total, lycopene, β-carotene, α-carotene, lutein/zeaxanthin, and β-cryptoxanthin) with CVD was explored by using multivariate logistic, linear and weighted quantile sum (WQS) regression analyses. 11,336 volunteers were enrolled eventually. Results: Multivariate model data showed that lutein/zeaxanthin, α-carotene, lycopene, and β-cryptoxanthin were negatively associated with the incidence of CVD (P was less than 0.05). In comparison with the first quartile, the fourth quartile was associated with α-carotene ([OR] = 0.61 [0.47-0.79]), β-cryptoxanthin (OR = 0.67 [0.50-0.89]), lutein (OR = 0.69 [0.54- 0.86]), and lycopene (OR = 0.53 [0.41-0.67]). WQS analysis revealed that serum carotenoids had negative correlation with CVD (P was less than 0.001). Additionally, dose-response analysis demonstrated a negative linear association of hypertension with all the carotenoids involved (P was larger than 0.05 for non-linearity). Conclusions: The concentration of serum carotenoids had negative correlation with the prevalence of CVD, with a more significant protective effect against heart attack and stroke.

7,041 views

39 citations

ORIGINAL RESEARCH
14 July 2023
Evaluation of the safety and potential lipid-lowering effects of oral hydrogen-rich coral calcium (HRCC) capsules in patients with metabolic syndrome: a prospective case series study
Szu-Han Chiu, 10 more and Po-Jen Hsiao

5,403 views

6 citations

Protective effects and molecular mechanisms of tea polyphenols on cardiovascular diseases
Aging is the most important factor contributing to cardiovascular diseases (CVDs), and the incidence and severity of cardiovascular events tend to increase with age. Currently, CVD is the leading cause of death in the global population. In-depth analysis of the mechanisms and interventions of cardiovascular aging and related diseases is an important basis for achieving healthy aging. Tea polyphenols (TPs) are the general term for the polyhydroxy compounds contained in tea leaves, whose main components are catechins, flavonoids, flavonols, anthocyanins, phenolic acids, condensed phenolic acids and polymeric phenols. Among them, catechins are the main components of TPs. In this article, we provide a detailed review of the classification and composition of teas, as well as an overview of the causes of aging-related CVDs. Then, we focus on ten aspects of the effects of TPs, including anti-hypertension, lipid-lowering effects, anti-oxidation, anti-inflammation, anti-proliferation, anti-angiogenesis, anti-atherosclerosis, recovery of endothelial function, anti-thrombosis, myocardial protective effect, to improve CVDs and the detailed molecular mechanisms.

13,640 views

74 citations

ORIGINAL RESEARCH
29 June 2023
The micronutrient content of the diet is correlated with serum glucose biomarkers and lipid profile and is associated with the odds of being overweight/obese—a case-control study
Farhad Vahid, 2 more and Torsten Bohn

4,361 views

9 citations

The contradictory role of branched-chain amino acids in lifespan and insulin resistance
REVIEW
20 June 2023
The contradictory role of branched-chain amino acids in lifespan and insulin resistance
He Yao, 3 more and Yinghua Liu

20,219 views

47 citations

REVIEW
5 May 2023
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy
Jiahao Bao, 7 more and Hongbo Yu
Iron metabolism and ferroptosis in diabetic bone loss: from mechanism to therapy
Osteoporosis, one of the most serious and common complications of diabetes, has affected the quality of life of a large number of people in recent years. Although there are many studies on the mechanism of diabetic osteoporosis, the information is still limited and there is no consensus. Recently, researchers have proven that osteoporosis induced by diabetes mellitus may be connected to an abnormal iron metabolism and ferroptosis inside cells under high glucose situations. However, there are no comprehensive reviews reported. Understanding these mechanisms has important implications for the development and treatment of diabetic osteoporosis. Therefore, this review elaborates on the changes in bones under high glucose conditions, the consequences of an elevated glucose microenvironment on the associated cells, the impact of high glucose conditions on the iron metabolism of the associated cells, and the signaling pathways of the cells that may contribute to diabetic bone loss in the presence of an abnormal iron metabolism. Lastly, we also elucidate and discuss the therapeutic targets of diabetic bone loss with relevant medications which provides some inspiration for its cure.

7,840 views

33 citations

ORIGINAL RESEARCH
17 April 2023
Higher dietary magnesium and potassium intake are associated with lower body fat in people with impaired glucose tolerance
Natural Chu, 7 more and Elaine Chow
Higher dietary magnesium and potassium intake are associated with lower body fat in people with impaired glucose tolerance
Introduction: Obesity and diabetes are public health concerns worldwide, but few studies have examined the habitual intake of minerals on body composition in people with prediabetes. Methods: In this prospective cross-sectional study, 155 Chinese subjects with IGT (median age: 59(53-62) years, 58% female) had an assessment of body composition including body fat percentage, oral glucose tolerance tests (OGTT), Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) and 3-day food records from nutritional programme analysis. Results: Dietary intake of minerals was negatively correlated with body fat. People with obesity had the lowest daily consumption of iron median (IQR) 10.3 (6.9-13.3) mg, magnesium 224 (181-282) mg, and potassium 1973 (1563-2357) mg when compared to overweight (10.5 (8.0-14.5) mg, 273 (221-335) mg, and 2204 (1720-2650) mg) and normal weight individuals (13.2 (10.0-18.6) mg, 313 (243-368) mg, and 2295 (1833-3037) mg) (p = 0.008, < 0.0001 and 0.013 respectively). Amongst targeted minerals, higher dietary magnesium and potassium intake remained significantly associated with lower body fat after the adjustment of age, gender, macronutrients, fiber, and physical activity. Conclusion: Dietary magnesium and potassium intake may be associated with lower body fat in people with impaired glucose tolerance. Inadequate dietary mineral intake may play contribute to obesity and metabolic disorders independent of macronutrients and fiber consumption.

14,892 views

17 citations

ORIGINAL RESEARCH
14 April 2023
Single and combined associations of blood lead and essential metals with serum lipid profiles in community-dwelling adults
Heng Wan, 11 more and Jie Shen

3,232 views

14 citations

5,813 views

20 citations

REVIEW
16 January 2023
Recent advances in the application of ionomics in metabolic diseases
Yan Zhang, 3 more and Huimin Ying

6,779 views

20 citations